Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Recro Pharma, Inc. | 73,620 | reported | 08 Apr 2024 | tx 15+468,978−372,954 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Apr 2024 | TENDER | Recro Pharma, Inc. | 153,923 | 1.10 USD | |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 73,620 | 1.10 USD | |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 27,229 | — | deriv |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 118,182 | — | deriv |
| 28 Aug 2023 | PURCHASE | Recro Pharma, Inc. | 37,500 | 0.40 USD | first after silence |
| 17 May 2023 | GRANT_AWARD | Recro Pharma, Inc. | 73,620 | — | |
| 17 May 2023 | GRANT_AWARD | Recro Pharma, Inc. | 27,229 | 0.00 USD | deriv |
| 18 May 2022 | GRANT_AWARD | Recro Pharma, Inc. | 87,500 | — | |
| 18 May 2022 | GRANT_AWARD | Recro Pharma, Inc. | 118,182 | 0.00 USD | deriv |
| 18 Mar 2022 | PURCHASE | Recro Pharma, Inc. | 1,000 | 2.15 USD | |
| 17 Nov 2021 | PURCHASE | Recro Pharma, Inc. | 1,000 | 1.69 USD | |
| 20 Apr 2021 | GRANT_AWARD | Recro Pharma, Inc. | 26,923 | 0.00 USD | |
| 20 Apr 2021 | GRANT_AWARD | Recro Pharma, Inc. | 38,012 | 0.00 USD | deriv |
| 09 Feb 2021 | EXERCISE | Recro Pharma, Inc. | 20,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 28 Aug 2023.